Effect of gastrointestinal gas on the temperature distribution in pancreatic cancer hyperthermia treatment planning

References

• SEER database. [cited 2020 Oct 28]. Available from: https://seer.cancer.gov/statfacts/html/pancreas.html.
   Google Scholar
• Janssen QP, O'Reilly EM, van Eijck CHJ, et al. Neoadjuvant treatment in patients with resectable and borderline resectable pancreatic cancer. Front Oncol. 2020;10:41.
   PubMed Web of Science ®Google Scholar
• Conroy T, Hammel P, Hebbar M, et al. FOLFIRINOX or Gemcitabine as adjuvant therapy for pancreatic cancer. N Engl J Med. 2018;379(25):2395–2406.
   PubMed Web of Science ®Google Scholar
• Adamska A, Elaskalani O, Emmanouilidi A, et al. Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. Adv Biol Regul. 2018;68:77–87.
   PubMedGoogle Scholar
• Seshacharyulu P, Baine MJ, Souchek JJ, et al. Biological determinants of radioresistance and their remediation in pancreatic cancer. Biochim Biophys Acta Rev Cancer. 2017;1868(1):69–92.
   PubMed Web of Science ®Google Scholar
• Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiotherapy. Clin Oncol (R Coll Radiol). 2007;19(6):418–426.
   PubMed Web of Science ®Google Scholar
• Issels RD. Hyperthermia adds to chemotherapy. Eur J Cancer. 2008;44(17):2546–2554.
   PubMed Web of Science ®Google Scholar
• Oei AL, Kok HP, Oei SB, et al. Molecular and biological rationale of hyperthermia as radio- and chemosensitizer. Adv Drug Deliv Rev. 2020;163-164:84–97.
   PubMed Web of Science ®Google Scholar
• van Rhoon GC, Franckena M, Ten Hagen TLM. A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy. Adv Drug Deliv Rev. 2020;163-164:145–156.
   PubMed Web of Science ®Google Scholar
• Issels RD, Lindner LH, Verweij J, European Organization for the Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group and the European Society for Hyperthermic Oncology, et al. Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial. JAMA Oncol. 2018;4(4):483–492.
   PubMed Web of Science ®Google Scholar
• Colombo R, Salonia A, Leib Z, et al. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU Int. 2011;107(6):912–918.
   PubMed Web of Science ®Google Scholar
• Liem EIML, Crezee H, de la Rosette JJ, et al. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations. Int J Hyperthermia. 2016;32(4):363–373.
   PubMed Web of Science ®Google Scholar
• Arends TJH, Nativ O, Maffezzini M, et al. Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin C versus bacillus Calmette-Guérin for adjuvant treatment of patients with intermediate- and high-risk non–muscle-invasive bladder cancer. Eur Urol. 2016;69(6):1046–1052.
   PubMed Web of Science ®Google Scholar
• Franckena M, Fatehi D, de Bruijne M, et al. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia. Eur J Cancer. 2009;45(11):1969–1978.
   PubMed Web of Science ®Google Scholar
• Kroesen M, Mulder HT, van Holthe JML, et al. Confirmation of thermal dose as a predictor of local control in cervical carcinoma patients treated with state-of-the-art radiation therapy and hyperthermia. Radiother Oncol. 2019;140:150–158.
   PubMed Web of Science ®Google Scholar
• Bakker A, van der Zee J, van Tienhoven G, et al. Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity: a systematic review. Int J Hyperthermia. 2019;36(1):1024–1039.
   PubMed Web of Science ®Google Scholar
• Cihoric N, Tsikkinis A, van Rhoon G, et al. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int J Hyperthermia. 2015;31(6):609–614.
   PubMed Web of Science ®Google Scholar
• Datta NR, Gómez Ordóñez S, Gaipl US, et al. Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future. Cancer Treat Rev. 2015;41(9):742–753.
   PubMed Web of Science ®Google Scholar
• Ohguri T, Imada H, Yahara K, et al. Concurrent chemoradiotherapy with gemcitabine plus regional hyperthermia for locally advanced pancreatic carcinoma: initial experience. Radiat Med. 2008;26(10):587–596.
   PubMedGoogle Scholar
• Maluta S, Schaffer M, Pioli F, et al. Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial. Strahlenther Onkol. 2011;187(10):619–625.
   PubMed Web of Science ®Google Scholar
• van der Horst A, Versteijne E, Besselink MGH, et al. The clinical benefit of hyperthermia in pancreatic cancer: a systematic review. Int J Hyperthermia. 2018;34(7):969–979.
   PubMed Web of Science ®Google Scholar
• He M, Sun J, Zhao D, et al. Modified-FOLFIRINOX combined with deep regional hyperthermia in pancreatic cancer: a retrospective study in Chinese patients. Int J Hyperthermia. 2019;36(1):394–402.
   PubMed Web of Science ®Google Scholar
• Datta NR, Pestalozzi B, Clavien P-A, members of the HEATPAC Trial Group, et al. "HEATPAC" - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer”. Radiat Oncol. 2017;12(1):183.
   PubMed Web of Science ®Google Scholar
• Issels RD. 2012. Hyperthermia European Adjuvant Trial (HEAT). ClinicalTrials.gov. Identifier: NCT01077427. [cited 2020 Jun 7]. Available from: https://clinicaltrials.gov/ct2/show/NCT01077427.
   Google Scholar
• Helderman R, Löke DR, Verhoeff J, et al. The temperature-dependent effectiveness of platinum-based drugs Mitomycin-C and 5-FU during hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer cell lines. Cells. 2020;9(8):1775.
   PubMed Web of Science ®Google Scholar
• Urano M, Ling CC. Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro. Int J Hyperthermia. 2002;18(4):307–315.
   PubMed Web of Science ®Google Scholar
• Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10(6):787–800.
   PubMed Web of Science ®Google Scholar
• van den Tempel N, Laffeber C, Odijk H, et al. The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination. Oncotarget. 2017;8(27):44593–44604.
   PubMedGoogle Scholar
• Dewhirst MW, Vujaskovic Z, Jones E, et al. Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia. 2005;21(8):779–790.
   PubMed Web of Science ®Google Scholar
• Frey B, Weiss E-M, Rubner Y, et al. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia. 2012;28(6):528–542.
   PubMed Web of Science ®Google Scholar
• Kok HP, Cressman ENK, Brace CL, et al. Heating technology for malignant tumors: a review. Int J Hyperthermia. 2020;37(1):711–741.
   PubMed Web of Science ®Google Scholar
• Kok HP, Wust P, Stauffer PR, et al. Current state of the art of regional hyperthermia treatment planning: a review. Radiat Oncol. 2015;10:196.
   PubMed Web of Science ®Google Scholar
• Kok HP, Ciampa S, de Kroon-Oldenhof R, et al. Toward online adaptive hyperthermia treatment planning: Correlation between measured and simulated specific absorption rate changes caused by phase steering in patients. Int J Radiat Oncol Biol Phys. 2014;90(2):438–445.
   PubMed Web of Science ®Google Scholar
• van Haaren PMA, Kok HP, van den Berg CAT, et al. On verification of hyperthermia treatment planning for cervical carcinoma patients. Int J Hyperthermia. 2007;23(3):303–314.
   PubMed Web of Science ®Google Scholar
• Bellizzi GG, Drizdal T, van Rhoon GC, et al. Predictive value of SAR based quality indicators for head and neck hyperthermia treatment quality. Int J Hyperthermia. 2019;36(1):455–4647.
   Web of Science ®Google Scholar
• Kok HP, van Haaren PMA, van de Kamer JB, et al. High-resolution temperature-based optimization for hyperthermia treatment planning. Phys Med Biol. 2005;50(13):3127–3141.
   PubMed Web of Science ®Google Scholar
• Kok HP, Korshuize-van Straten L, Bakker A, et al. Online adaptive hyperthermia treatment planning during locoregional heating to suppress treatment-limiting hot spots. Int J Radiat Oncol Biol Phys. 2017;99(4):1039–1047.
   PubMed Web of Science ®Google Scholar
• Franckena M, Canters R, Termorshuizen F, et al. Clinical implementation of hyperthermia treatment planning guided steering: a cross over trial to assess its current contribution to treatment quality. Int J Hyperthermia. 2010;26(2):145–157.
   PubMed Web of Science ®Google Scholar
• Li Y, Hoisak JDP, Li N, et al. Dosimetric benefit of adaptive re-planning in pancreatic cancer stereotactic body radiotherapy. Med Dosim. 2015;40(4):318–324.
   PubMed Web of Science ®Google Scholar
• van der Horst A, Houweling AC, van Tienhoven G, et al. Dosimetric effects of anatomical changes during fractionated photon radiation therapy in pancreatic cancer patients. J Appl Clin Med Phys. 2017;18(6):142–151.
   PubMed Web of Science ®Google Scholar
• Houweling AC, Fukata K, Kubota Y, et al. The impact of interfractional anatomical changes on the accumulated dose in carbon ion therapy of pancreatic cancer patients. Radiother Oncol. 2016;119(2):319–325.
   PubMed Web of Science ®Google Scholar
• Kok HP, Kotte ANTJ, Crezee J. Planning, optimisation and evaluation of hyperthermia treatments. Int J Hyperthermia. 2017; 33(6):593–607.
   PubMed Web of Science ®Google Scholar
• Veiga C, McClelland J, Moinuddin S, et al. Toward adaptive radiotherapy for head and neck patients: feasibility study on using CT-to-CBCT deformable registration for "dose of the day" calculations. Med Phys. 2014;41(3):031703.
   PubMed Web of Science ®Google Scholar
• Bol GH, Kotte AN, van der Heide UA, et al. Simultaneous multi-modality ROI delineation in clinical practice. Comput Methods Programs Biomed. 2009;96(2):133–140.
   PubMed Web of Science ®Google Scholar
• Zweije R, Kok HP, Bakker A, et al. Technical and clinical evaluation of the ALBA-4D 70MHz loco-regional hyperthermia system. 48th European Microwave Conference (EuMC). 2018; Madrid. p. 328–331.
   Google Scholar
• Crezee J, van Haaren PM, Westendorp H, et al. Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: a preclinical study. Int J Hyperthermia. 2009;25(7):581–592.
   PubMed Web of Science ®Google Scholar
• Kok HP, de Greef M, Borsboom PP,.org/10.3, et al. Improved power steering with double and triple ring waveguide systems: the impact of the operating frequency. Int J Hyperthermia. 2011;27(3):224–239.
   PubMed Web of Science ®Google Scholar
• Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol. 1948;1(2):93–122.
   PubMed Web of Science ®Google Scholar
• Moritz AR, Henriques FC. Studies of thermal injury: II. The relative importance of time and surface temperature in the causation of cutaneous burns. Am J Pathol. 1947;23(5):695–720.
   PubMed Web of Science ®Google Scholar
• Stoll AM, Greene LC. Relationship between pain and tissue damage due to thermal radiation. J Appl Physiol. 1959;14(3):373–382.
   PubMed Web of Science ®Google Scholar
• Bakker A, Kolff MW, Holman R, et al. Thermal skin damage during reirradiation and hyperthermia is time-temperature dependent. Int J Radiat Oncol Biol Phys. 2017;98(2):392–399.
   PubMed Web of Science ®Google Scholar
• Core Team R. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2015. Available from: http://www.R-project.org/
   Google Scholar
• Hendifar AE, Petzel MQB, Zimmers TA, Precision Promise Consortium, et al. Pancreas cancer-associated weight loss. Oncologist. 2019;24(5):691–701.
   PubMed Web of Science ®Google Scholar
• Okura T, Fujii M, Shiode J, et al. Impact of body mass index on survival of pancreatic cancer patients in Japan. Acta Med Okayama. 2018;72(2):129–135.
   PubMed Web of Science ®Google Scholar
• Crezee H, van Leeuwen CM, Oei AL, et al. Thermoradiotherapy planning: integration in routine clinical practice. Int J Hyperthermia. 2016;32(1):41–49.
   PubMed Web of Science ®Google Scholar
• Yarmolenko PS, Moon EJ, Landon C, et al. Thresholds for thermal damage to normal tissues: an update. Int J Hyperthermia. 2011;27(4):320–343.
   PubMed Web of Science ®Google Scholar
• Wust P, Nadobny J, Seebass M, et al. Influence of patient models and numerical methods on predicted power deposition patterns. Int J Hyperthermia. 1999;15(6):519–540.
   PubMed Web of Science ®Google Scholar
• Kok HP, de Kroon-Oldenhof R, Korshuize-van Straten L, et al. RF heating of pancreatic tumours guided by hyperthermia treatment planning and limited thermometry. 48th European Microwave Conference (EuMC). 2018. Madrid:332–335.
   Google Scholar
• Alderliesten T, Sonke J-J, Bosman PAN. Deformable image registration by multi-objective optimization using a dual-dynamic transformation model to account for large anatomical differences. Proc. of SPIE. 2013;8669:866910.
   Google Scholar
• van der Horst A, Wognum S, Dávila Fajardo R, et al. Interfractional position variation of pancreatic tumors quantified using intratumoral fiducial markers and daily cone beam computed tomography. Int J Radiat Oncol Biol Phys. 2013;87(1):202–208.
   PubMed Web of Science ®Google Scholar
• Canters RA, Franckena M, Paulides MM, et al. Patient positioning in deep hyperthermia: influences of inaccuracies, signal correction possibilities and optimization potential. Phys Med Biol. 2009;54(12):3923–3936.
   PubMed Web of Science ®Google Scholar
• Bruggmoser G, Bauchowitz S, Canters R, et al. Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia: quality management in regional deep hyperthermia. Strahlenther Onkol. 2012;188(S2):198–211.
   PubMed Web of Science ®Google Scholar
• Gellermann J, Hildebrandt B, Issels R, et al. Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry. Cancer. 2006;107(6):1373–1382.
   PubMed Web of Science ®Google Scholar
• Lüdemann L, Wlodarczyk W, Nadobny J, et al. Non-invasive magnetic resonance thermography during regional hyperthermia. Int J Hyperthermia. 2010;26(3):273–282.
   PubMed Web of Science ®Google Scholar
• Adibzadeh F, Sumser K, Curto S, et al. Systematic review of pre-clinical and clinical devices for magnetic resonance-guided radiofrequency hyperthermia. Int J Hyperthermia. 2020;37(1):15–27.
   PubMed Web of Science ®Google Scholar
• Wu M, Mulder HT, Baron P, et al. Correction of motion-induced susceptibility artifacts and B0 drift during proton resonance frequency shift-based MR thermometry in the pelvis with background field removal methods. Magn Reson Med. 2020;84(5):2495–2511.
   PubMed Web of Science ®Google Scholar
• Wu M, Mulder HT, Zur Y, et al. A phase-cycled temperature-sensitive fast spin echo sequence with conductivity bias correction for monitoring of mild RF hyperthermia with PRFS. MAGMA. 2019;32(3):369–380.
   PubMedGoogle Scholar
• Kothapalli SVVN, Altman MB, Zhu L, et al. Evaluation and selection of anatomic sites for magnetic resonance imaging-guided mild hyperthermia therapy: a healthy volunteer study. Int J Hyperthermia. 2018;34(8):1381–1389.
   PubMed Web of Science ®Google Scholar
• Winter L, Oberacker E, Paul K, et al. Magnetic resonance thermometry: methodology, pitfalls and practical solutions. Int J Hyperthermia. 2016;32(1):63–75.
   PubMed Web of Science ®Google Scholar